Coronary Artery Bypass Grafting vs Percutaneous Coronary Intervention and Long-term Mortality and Morbidity in Multivessel Disease Meta-analysis of Randomized Clinical Trials of the Arterial Grafting and Stenting Era

Creative Commons License

Sipahi I., Akay M. H., Dagdelen S., Blitz A., Alhan C.

JAMA INTERNAL MEDICINE, vol.174, no.2, pp.223-230, 2014 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 174 Issue: 2
  • Publication Date: 2014
  • Doi Number: 10.1001/jamainternmed.2013.12844
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.223-230
  • Acibadem Mehmet Ali Aydinlar University Affiliated: Yes


IMPORTANCE Recent trials of percutaneous coronary intervention (PCI) vs coronary artery bypass grafting (CABG) for multivessel disease were not designed to detect a difference in mortality and therefore were underpowered for this outcome. Consequently, the comparative effects of these 2 revascularization methods on long-term mortality are still unclear. In the absence of solid evidence for mortality difference, PCI is oftentimes preferred over CABG in these patients, given its less invasive nature.